Gryska David Winsider trades
In SEC Form 4 filings, Gryska David W is listed as Director of Celcuity Inc. (CELC) and Director of Forte Biosciences, Inc. (FBRX). Gryska David W reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 5.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-27
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CELCCelcuity Inc. | Oct 1 | Oct 5 | A | 893 | $0.00 | $0 | 893 | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | U | 5,940 | not reported | not reported | not reported | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | D · derivative | 2,000 | $25.50 | $51,000 | not reported | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | D · derivative | 1,000 | $20.00 | $20,000 | not reported | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | D · derivative | 2,000 | $8.60 | $17,200 | not reported | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | D · derivative | 31,000 | $7.54 | $233,740 | not reported | No | Form 4 |
| FBRXForte Biosciences, Inc. | Aug 27 | Aug 27 | D · derivative | 18,353 | not reported | not reported | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.